The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
Cyclooxygenase-2 expression is induced during human megakaryopoiesis and characterizes newly formed platelets
Open accessAbstract
Cyclooxygenase (COX)-1 or -2 and prostaglandin (PG) synthases catalyze the formation of various PGs and thromboxane (TX) A 2 . We have investigated the expression and activity of COX-1 and -2 during human megakaryocytopoiesis. We analyzed megakaryocytes from bone marrow biopsies and derived from thrombopoietin-treated CD34 + hemopoietic progenitor cells in culture. Platelets were obtained from healthy donors and patients with high platelet regeneration because of immune thrombocytopenia or peripheral blood stem cell transplantation. By immunocytochemistry, COX-1 was observed in CD34 + cells and in megakaryocytes at each stage of maturation, whereas COX-2 was induced after 6 days of culture, and remained detectable in mature megakaryocytes. CD34 + cells synthesized more PGE 2 than TXB 2 (214 ± 50 vs. 30 ± 10 pg/10 6 cells), whereas the reverse was true in mature megakaryocytes (TXB 2 8,440 ± 2,500 vs. PGE 2 906 ± 161 pg/10 6 cells). By immunostaining, COX-2 was observed in <10% of circulating platelets from healthy controls, whereas up to 60% of COX-2-positive platelets were found in patients. A selective COX-2 inhibitor reduced platelet production of both PGE 2 and TXB 2 to a significantly greater extent in patients than in healthy subjects. Finally, we found that COX-2 and the inducible PGE-synthase were coexpressed in mature megakaryocytes and in platelets. We conclude that both COX-isoforms contribute to prostanoid formation during human megakaryocytopoiesis and that COX-2-derived PGE 2 and TXA 2 may play an unrecognized role in inflammatory and hemostatic responses in clinical syndromes associated with high platelet turnover.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Coxibs, Selective Inhibitors of Cyclooxygenase-2
FitzGerald, G. A., & Patrono, C. (2001) · New England Journal of Medicine · doi:10.1056/nejm200108093450607 · Cited by 1,565
Self-citationEikelboom, J. W., Hirsh, J., Weitz, J. I., Johnston, M., Yi, Q., & Yusuf, S. (2002) · Circulation · doi:10.1161/01.cir.0000013777.21160.07 · Cited by 1,053
Jakobsson, P.-J., Thorén, S., Morgenstern, R., & Samuelsson, B. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.13.7220 · Cited by 996
Patrono, C., Coller, B., Dalen, J. E., Fitz Gerald, G. A., Fuster, V., Gent, M., Hirsh, J., & Roth, G. (2001) · Chest · doi:10.1378/chest.119.1_suppl.39s · Cited by 963
Self-citationAspirin as an Antiplatelet Drug
Wood, A. J. J., & Patrono, C. (1994) · New England Journal of Medicine · doi:10.1056/nejm199405053301808 · Cited by 955
Self-citationPatrignani, P., Filabozzi, P., & Patrono, C. (1982) · Journal of Clinical Investigation · doi:10.1172/jci110576 · Cited by 937
Self-citationActivated platelets mediate inflammatory signaling by regulated interleukin 1β synthesis
Lindemann, S., Tolley, N. D., Dixon, D. A., McIntyre, T. M., Prescott, S. M., Zimmerman, G. A., & Weyrich, A. S. (2001) · The Journal of Cell Biology · doi:10.1083/jcb.200105058 · Cited by 697
Low dose aspirin and inhibition of thromboxane B2 production in healthy subjects
Patrono, C., Ciabattoni, G., Pinca, E., Pugliese, F., Castrucci, G., De Salvo, A., Satta, M. A., & Peskar, B. A. (1980) · Thrombosis Research · doi:10.1016/0049-3848(80)90066-3 · Cited by 651
Self-citationWhy there are two cyclooxygenase isozymes
Smith, W. L., & Langenbach, R. (2001) · Journal of Clinical Investigation · doi:10.1172/jci13271 · Cited by 611
Characterization of the human gene (PTGS2) encoding prostaglandin‐endoperoxide synthase 2
KOSAKA, T., MIYATA, A., IHARA, H., HARA, S., SUGIMOTO, T., TAKEDA, O., TAKAHASHI, E., & TANABE, T. (1994) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1994.tb18804.x · Cited by 383
Cited by
Platelet Activation and Atherothrombosis
Davì, G., & Patrono, C. (2007) · New England Journal of Medicine · doi:10.1056/nejmra071014 · Cited by 2,135
Self-citationAuthors/Task Force Members, Bassand, J.-P., Hamm, C. W., Ardissino, D., Boersma, E., Budaj, A., Fernandez-Aviles, F., Fox, K. A. A., Hasdai, D., Ohman, E. M., et al. (2007) · European Heart Journal · doi:10.1093/eurheartj/ehm161 · Cited by 1,849
Low-Dose Aspirin for the Prevention of Atherothrombosis
Patrono, C., García Rodríguez, L. A., Landolfi, R., & Baigent, C. (2005) · New England Journal of Medicine · doi:10.1056/nejmra052717 · Cited by 1,218
Self-citationComplications of the COX-2 Inhibitors Parecoxib and Valdecoxib after Cardiac Surgery
Nussmeier, N. A., Whelton, A. A., Brown, M. T., Langford, R. M., Hoeft, A., Parlow, J. L., Boyce, S. W., & Verburg, K. M. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa050330 · Cited by 1,092
Prostaglandin E2 regulates vertebrate haematopoietic stem cell homeostasis
North, T. E., Goessling, W., Walkley, C. R., Lengerke, C., Kopani, K. R., Lord, A. M., Weber, G. J., Bowman, T. V., Jang, I.-H., Grosser, T., et al. (2007) · Nature · doi:10.1038/nature05883 · Cited by 1,029
Patrono, C., Coller, B., Dalen, J. E., Fitz Gerald, G. A., Fuster, V., Gent, M., Hirsh, J., & Roth, G. (2001) · Chest · doi:10.1378/chest.119.1_suppl.39s · Cited by 963
Self-citationPatrono, C., Baigent, C., Hirsh, J., & Roth, G. (2008) · Chest · doi:10.1378/chest.08-0672 · Cited by 748
Self-citationPlatelet-Active Drugs: The Relationships Among Dose, Effectiveness, and Side Effects
Patrono, C., Coller, B., FitzGerald, G. A., Hirsh, J., & Roth, G. (2004) · Chest · doi:10.1378/chest.126.3_suppl.234s · Cited by 671
Self-citationRapezzi, C., Biagini, E., & Branzi, A. (2007) · European Heart Journal · doi:10.1093/eurheartj/ehm498 · Cited by 595
Prostanoids in health and disease
Smyth, E. M., Grosser, T., Wang, M., Yu, Y., & FitzGerald, G. A. (2009) · Journal of Lipid Research · doi:10.1194/jlr.r800094-jlr200 · Cited by 543
Weitz, J. I., Eikelboom, J. W., & Samama, M. M. (2012) · Chest · doi:10.1378/chest.11-2294 · Cited by 527
Hankey, G. J., & Eikelboom, J. W. (2006) · The Lancet · doi:10.1016/s0140-6736(06)68040-9 · Cited by 505
Platelets: signaling cells in the immune continuum
Weyrich, A. S., & Zimmerman, G. A. (2004) · Trends in Immunology · doi:10.1016/j.it.2004.07.003 · Cited by 414
Aspirin and Clopidogrel: Efficacy, Safety, and the Issue of Drug Resistance
Cattaneo, M. (2004) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000145980.39477.a9 · Cited by 411
Patrono, C. (2004) · European Heart Journal · doi:10.1016/j.ehj.2003.10.013 · Cited by 408
Self-citationEikelboom, J. W., Hirsh, J., Spencer, F. A., Baglin, T. P., & Weitz, J. I. (2012) · Chest · doi:10.1378/chest.11-2293 · Cited by 379
Guthikonda, S., Alviar, C. L., Vaduganathan, M., Arikan, M., Tellez, A., DeLao, T., Granada, J. F., Dong, J.-F., Kleiman, N. S., & Lev, E. I. (2008) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2008.05.031 · Cited by 337
Old and new generation lipid mediators in acute inflammation and resolution
Stables, M. J., & Gilroy, D. W. (2011) · Progress in Lipid Research · doi:10.1016/j.plipres.2010.07.005 · Cited by 334
Platelets: versatile effector cells in hemostasis, inflammation, and the immune continuum
Vieira-de-Abreu, A., Campbell, R. A., Weyrich, A. S., & Zimmerman, G. A. (2012) · Seminars in Immunopathology · doi:10.1007/s00281-011-0286-4 · Cited by 321
Aspirin resistance: definition, mechanisms and clinical read-outs
Patrono, C. (2003) · Journal of Thrombosis and Haemostasis · doi:10.1046/j.1538-7836.2003.00284.x · Cited by 299
Self-citationThe evolving role of platelets in inflammation
Weyrich, A. S., Lindemann, S., & Zimmerman, G. A. (2003) · Journal of Thrombosis and Haemostasis · doi:10.1046/j.1538-7836.2003.00304.x · Cited by 294
Zimmermann, N., Wenk, A., Kim, U., Kienzle, P., Weber, A.-A., Gams, E., Schrör, K., & Hohlfeld, T. (2003) · Circulation · doi:10.1161/01.cir.0000081770.51929.5a · Cited by 287
Mitchell, J. A., & Warner, T. D. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd1929 · Cited by 279
Chiang, N., Bermudez, E. A., Ridker, P. M., Hurwitz, S., & Serhan, C. N. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0405445101 · Cited by 266
Santilli, F., Rocca, B., De Cristofaro, R., Lattanzio, S., Pietrangelo, L., Habib, A., Pettinella, C., Recchiuti, A., Ferrante, E., Ciabattoni, G., et al. (2009) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2008.10.047 · Cited by 265
Self-citationPlatelet activation in obesity and metabolic syndrome
Santilli, F., Vazzana, N., Liani, R., Guagnano, M. T., & Davì, G. (2012) · Obesity Reviews · doi:10.1111/j.1467-789x.2011.00930.x · Cited by 258
Diabetes mellitus and thrombosis
Vazzana, N., Ranalli, P., Cuccurullo, C., & Davì, G. (2012) · Thrombosis Research · doi:10.1016/j.thromres.2011.11.052 · Cited by 257
Antithrombotic properties of aspirin and resistance to aspirin: beyond strictly antiplatelet actions
Undas, A., Brummel-Ziedins, K. E., & Mann, K. G. (2007) · Blood · doi:10.1182/blood-2006-01-010645 · Cited by 254
Metadata
- Authors
- Rocca, B., Secchiero, P., Ciabattoni, G., Ranelletti, F. O., Catani, L., Guidotti, L., Melloni, E., Maggiano, N., Zauli, G., & Patrono, C.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 2002-05-21
- Volume
- 99
- Issue
- 11
- Pages
- 7634-7639
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2020789281
- Cited by
- 317
- References
- 29
- FWCI
- 9.10
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.